Lymph Node Biopsy and Reconstruction
In the case of ductal carcinoma in situ, many surgeons opt to perform a sentinel lymph node biopsy alongside a simple mastectomy. This biopsy is crucial in determining whether the cancer has become invasive. However, it is important to note that a sentinel node biopsy cannot be conducted after this particular surgery. Following either type of surgery, women have the option to undergo breast reconstruction. However, those who have chosen breast-sparing surgery must wait until after radiation therapy before proceeding with reconstruction.
Alternative Treatments and Outlook
In the treatment of ductal carcinoma in situ (DCIS), endocrine therapy is commonly recommended. Numerous studies have indicated that certain types of DCIS can be effectively managed with endocrine therapy, significantly reducing the likelihood of breast cancer recurrence. However, it is important to note that some of these therapies may come with notable side effects, such as stroke, endometrial cancer, and pulmonary embolism. Consequently, it is crucial for patients to have open discussions with their doctors to fully comprehend the potential risks and benefits involved.
When diagnosed early, the prognosis for DCIS is highly promising. With proper and successful treatment, women can expect to have a normal life expectancy. Conversely, if DCIS is not detected in its early stages or if it displays aggressive characteristics, there is a risk of it progressing into invasive breast cancer. Unfortunately, invasive breast cancer carries a significantly higher mortality rate.